Institutional investors hold a majority ownership of ENZN through the 51.80% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JAMES INVESTMENT RESEARCH, INC. Bought 18.6 Thousand shares of Enzon Pharmaceuticals Inc